These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 33432548)

  • 21. Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures.
    Austin M; Yang YC; Vittinghoff E; Adami S; Boonen S; Bauer DC; Bianchi G; Bolognese MA; Christiansen C; Eastell R; Grauer A; Hawkins F; Kendler DL; Oliveri B; McClung MR; Reid IR; Siris ES; Zanchetta J; Zerbini CA; Libanati C; Cummings SR;
    J Bone Miner Res; 2012 Mar; 27(3):687-93. PubMed ID: 22095631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do proximal hip geometry, trabecular microarchitecture, and prevalent vertebral fractures differ in postmenopausal women with type 2 diabetes mellitus? A cross-sectional study from a teaching hospital in southern India.
    Paul J; Devarapalli V; Johnson JT; Cherian KE; Jebasingh FK; Asha HS; Kapoor N; Thomas N; Paul TV
    Osteoporos Int; 2021 Aug; 32(8):1585-1593. PubMed ID: 33502560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of high fracture risk patients in routine clinical practice.
    Lesnyak O; Gladkova E; Aleksandrov N; Belaya Z; Belova K; Bezlyudnaya N; Dobrovolskaya O; Dreval A; Ershova O; Grebennikova T; Kryukova I; Mazurenko S; Priymak D; Rozhinskaya L; Samigullina R; Solodovnikov A; Toroptsova N
    Arch Osteoporos; 2020 Nov; 15(1):184. PubMed ID: 33219455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship Between Bone Mineral Density and Risk of Vertebral Fractures with Denosumab Treatment in Japanese Postmenopausal Women and Men with Osteoporosis.
    Okubo N; Matsui S; Matsumoto T; Sugimoto T; Hosoi T; Osakabe T; Watanabe K; Takami H; Shiraki M; Nakamura T
    Calcif Tissue Int; 2020 Dec; 107(6):559-566. PubMed ID: 32839843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalent vertebral fracture is dominantly associated with spinal microstructural deterioration rather than bone mineral density in patients with type 2 diabetes mellitus.
    Yamamoto M; Yamauchi M; Sugimoto T
    PLoS One; 2019; 14(9):e0222571. PubMed ID: 31525243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis.
    McClung MR; Lippuner K; Brandi ML; Zanchetta JR; Bone HG; Chapurlat R; Hans D; Wang A; Zapalowski C; Libanati C
    Osteoporos Int; 2017 Oct; 28(10):2967-2973. PubMed ID: 28748386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials.
    Bouxsein ML; Chen P; Glass EV; Kallmes DF; Delmas PD; Mitlak BH
    J Bone Joint Surg Am; 2009 Jun; 91(6):1329-38. PubMed ID: 19487509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Once-Weekly Injection of Low-Dose Teriparatide (28.2 μg) Reduced the Risk of Vertebral Fracture in Patients with Primary Osteoporosis.
    Fujita T; Fukunaga M; Itabashi A; Tsutani K; Nakamura T
    Calcif Tissue Int; 2014 Feb; 94(2):170-5. PubMed ID: 23963633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Teriparatide treatment of severe osteoporosis reduces the risk of vertebral fractures compared with standard care in routine clinical practice.
    Oswald AJ; Berg J; Milne G; Ralston SH
    Calcif Tissue Int; 2014 Feb; 94(2):176-82. PubMed ID: 24026567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rates of osteoporosis screening and treatment following vertebral fracture.
    Barton DW; Behrend CJ; Carmouche JJ
    Spine J; 2019 Mar; 19(3):411-417. PubMed ID: 30142455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Independent association of bone mineral density and trabecular bone score to vertebral fracture in male subjects with chronic obstructive pulmonary disease.
    Watanabe R; Tai N; Hirano J; Ban Y; Inoue D; Okazaki R
    Osteoporos Int; 2018 Mar; 29(3):615-623. PubMed ID: 29167970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial.
    Miller PD; Hattersley G; Riis BJ; Williams GC; Lau E; Russo LA; Alexandersen P; Zerbini CA; Hu MY; Harris AG; Fitzpatrick LA; Cosman F; Christiansen C;
    JAMA; 2016 Aug; 316(7):722-33. PubMed ID: 27533157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Degraded microarchitecture by low trabecular bone score is associated with prevalent vertebral fractures in patients with systemic lupus erythematosus.
    Lai EL; Huang WN; Chen HH; Chen JP; Chen DY; Hsieh TY; Hung WT; Lai KL; Lin CT; Tang KT; Chen YM; Chen YH
    Arch Osteoporos; 2020 Mar; 15(1):54. PubMed ID: 32221755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vertebral Fracture Risk in Diabetic Elderly Men: The MrOS Study.
    Napoli N; Schwartz AV; Schafer AL; Vittinghoff E; Cawthon PM; Parimi N; Orwoll E; Strotmeyer ES; Hoffman AR; Barrett-Connor E; Black DM;
    J Bone Miner Res; 2018 Jan; 33(1):63-69. PubMed ID: 28861910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients with prior vertebral or hip fractures treated with teriparatide in the Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) observational study.
    Beall DP; Feldman RG; Gordon ML; Gruber BL; Lane JM; Valenzuela G; Yim D; Alam J; Krege JH; Krohn K
    Osteoporos Int; 2016 Mar; 27(3):1191-1198. PubMed ID: 26556737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The utility of lumbar spine trabecular bone score and femoral neck bone mineral density for identifying asymptomatic vertebral fractures in well-compensated type 2 diabetic patients.
    Zhukouskaya VV; Eller-Vainicher C; Gaudio A; Privitera F; Cairoli E; Ulivieri FM; Palmieri S; Morelli V; Grancini V; Orsi E; Masserini B; Spada AM; Fiore CE; Chiodini I
    Osteoporos Int; 2016 Jan; 27(1):49-56. PubMed ID: 26138582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-fracture Risk Assessment: Target the Centrally Sited Fractures First! A Substudy of NoFRACT.
    Borgen TT; Bjørnerem Å; Solberg LB; Andreasen C; Brunborg C; Stenbro MB; Hübschle LM; Froholdt A; Figved W; Apalset EM; Gjertsen JE; Basso T; Lund I; Hansen AK; Stutzer JM; Omsland TK; Nordsletten L; Frihagen F; Eriksen EF
    J Bone Miner Res; 2019 Nov; 34(11):2036-2044. PubMed ID: 31310352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Teriparatide versus bisphosphonates for treatment of postmenopausal osteoporosis: A meta-analysis.
    Yuan F; Peng W; Yang C; Zheng J
    Int J Surg; 2019 Jun; 66():1-11. PubMed ID: 30890377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bisphosphonates for steroid-induced osteoporosis.
    Allen CS; Yeung JH; Vandermeer B; Homik J
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD001347. PubMed ID: 27706804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of bisphosphonates against osteoporosis in adult men: a meta-analysis of randomized controlled trials.
    Chen L; Wang G; Zheng F; Zhao H; Li H
    Osteoporos Int; 2015 Sep; 26(9):2355-63. PubMed ID: 25944731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.